Optimising use of SGLT2 inhibitors in hospital patients

Introduction Sodium-glucose co-transporter-2 (SGLT2) inhibitors act on the renal proximal convoluted tubule, which inhibits SGLT2, to reduce the absorption of sodium and glucose into the blood and encourage their excretion in urine1. These medicines have shown to improve glycaemic control, lower HbA1c and encourage weight reduction in people diagnosed with type 2 diabetes mellitus (T2DM)1. […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2024.1.341713
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Optimising use of SGLT2 inhibitors in hospital patients

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Diabetes Treatment and Management

article

Optimising use of SGLT2 inhibitors in hospital patients

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Openalex Percentile: Top 100%

Diabetes Treatment and Management

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Optimising use of SGLT2 inhibitors in hospital patients · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS